Sat-18-12-2021, 22:10 PM
Rinvoq goes for psoriatic arthritis approval
|
Thu-13-01-2022, 14:27 PM
Update: The National Institute for Health and Care Excellence (NICE) has recommended Rinvoq (upadacitinib) as a treatment option for certain patients with active psoriatic arthritis (PsA) in England and Wales.
Mon-17-01-2022, 21:12 PM
(Thu-13-01-2022, 14:27 PM)Fred Wrote: Update: The National Institute for Health and Care Excellence (NICE) has recommended Rinvoq (upadacitinib) as a treatment option for certain patients with active psoriatic arthritis (PsA) in England and Wales.I'll keep my head down and hope it's never offered me as an option |
« Next Oldest | Next Newest »
|
Possibly Related Threads… | |||||
Thread | Author | Replies | Views | Last Post | |
Bimzelx gets recommendation for psoriatic arthritis in the EU | Fred | 2 | 1,813 |
Sat-10-06-2023, 14:33 PM Last Post: Forest Walker |
|
Tremfya for psoriatic arthritis phase 3b data | Fred | 0 | 1,145 |
Wed-31-05-2023, 16:26 PM Last Post: Fred |
|
Bimzelx and psoriatic arthritis long term data | Fred | 0 | 1,034 |
Wed-31-05-2023, 14:00 PM Last Post: Fred |
|
Otezla and psoriatic arthritis new research | Fred | 0 | 966 |
Wed-31-05-2023, 11:39 AM Last Post: Fred |
|
Izokibep and psoriatic arthritis 46 week data | Fred | 0 | 1,206 |
Tue-11-04-2023, 13:35 PM Last Post: Fred |
Users browsing this thread: 1 Guest(s)